Erez Raphael - 05 Nov 2021 Form 4 Insider Report for DarioHealth Corp. (DRIO)

Role
Chief Executive Officer, Director
Signature
/s/ Erez Raphael
Issuer symbol
DRIO
Transactions as of
05 Nov 2021
Net transactions value
-$19,073
Form type
4
Filing time
09 Nov 2021, 19:51:54 UTC
Previous filing
05 Nov 2021
Next filing
20 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DRIO Common Stock Sale $3,810 -200 -0.02% $19.05* 839,059 05 Nov 2021 Direct F1, F2
transaction DRIO Common Stock Sale $15,263 -800 -0.1% $19.08* 838,259 08 Nov 2021 Direct F1, F3
holding DRIO Common Stock 37,876 05 Nov 2021 By Dicilyon Consulting and Investment Ltd. F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2021.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.01 to $19.09, inclusive. The Reporting Person undertakes to provide to DarioHealth Corp. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2).
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.00 to $19.19, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3).
F4 The amount shown represents the beneficial ownership of the issuer's securities held by Dicilyon Consulting and Investment Ltd. which may be deemed to be attributable to Mr. Raphael because Mr. Raphael possesses voting and dispositive power over the securities held by Dicilyon Consulting and Investment Ltd. by virtue of a proxy. Mr. Raphael disclaims beneficial ownership of the securities set forth herein.